Victory for UCI as WADA bans glucocorticoids

UCI president David Lappartient attended the 2020 Tour Down Under in Adelaide, Australia
UCI president David Lappartient (Image credit: Bettini Photo)

The UCI announced on Wednesday it will welcome an in-competition ban under the World Anti-Doping Agency (WADA) code on all forms of injectable glucocorticosteroids which will come into effect in 2022.

The drugs, described by retired professional David Millar as the "most potent" drug he used during his career, have been abused in pro cycling for decades but allowed with medical justification. Lance Armstrong famously avoided punishment for a Triamcinolone positive with a backdated Therapeutic Use Exemption (TUE) during the 1999 Tour de France.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Cyclingnews is the world's leader in English-language coverage of professional cycling. Started in 1995 by University of Newcastle professor Bill Mitchell, the site was one of the first to provide breaking news and results over the internet in English. The site was purchased by Knapp Communications in 1999, and owner Gerard Knapp built it into the definitive voice of pro cycling. Since then, major publishing house Future PLC has owned the site and expanded it to include top features, news, results, photos and tech reporting. The site continues to be the most comprehensive and authoritative English voice in professional cycling.